Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueInventory Average

RedHill Biopharma (RDHL) FCF Margin (2016 - 2022)

Historic FCF Margin for RedHill Biopharma (RDHL) over the last 11 years, with Q4 2022 value amounting to 18.92%.

  • RedHill Biopharma's FCF Margin rose 483900.0% to 18.92% in Q4 2022 from the same period last year, while for Dec 2023 it was 13.31%, marking a year-over-year increase of 336000.0%. This contributed to the annual value of 0.0% for FY2024, which is 5483800.0% up from last year.
  • Latest data reveals that RedHill Biopharma reported FCF Margin of 18.92% as of Q4 2022, which was up 483900.0% from 34.22% recorded in Q3 2022.
  • RedHill Biopharma's 5-year FCF Margin high stood at 18.92% for Q4 2022, and its period low was 983.14% during Q1 2020.
  • For the 5-year period, RedHill Biopharma's FCF Margin averaged around 297.97%, with its median value being 88.72% (2021).
  • Over the last 5 years, RedHill Biopharma's FCF Margin had its largest YoY gain of 16356400bps in 2018, and its largest YoY loss of -210318500bps in 2018.
  • Quarter analysis of 5 years shows RedHill Biopharma's FCF Margin stood at 602.58% in 2018, then crashed by -44bps to 870.19% in 2019, then skyrocketed by 93bps to 58.97% in 2020, then fell by -14bps to 67.31% in 2021, then soared by 72bps to 18.92% in 2022.
  • Its last three reported values are 18.92% in Q4 2022, 34.22% for Q3 2022, and 89.49% during Q2 2022.